Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024)

Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024)

Abstract Background Patient-reported outcomes (PROs) in systemic rheumatic diseases (SRDs) are in the forefront of clinical research. However, a comprehensive evaluation of PROs in pivotal trials supporting SRD drug approval is lacking. Objective This study aims to systematically characterize the us...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Xie, Yang Liu, Yunhe Qin, Geng Yin, Xiaoyuan Chen, Qibing Xie
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Health and Quality of Life Outcomes
Subjects:
Patient reported outcomes
Systemic rheumatic diseases
Drug approval
Reporting quality
Online Access:https://doi.org/10.1186/s12955-025-02386-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items